Acousia Therapeutics GmbH: Acousia Therapeutics to present its first-in-class hearing loss treatment program with ACOU085 at the 2nd Inner Ear Therapeutics Summit in Boston
11.5.2022 10:03:28 CEST | news aktuell GmbH | Press release
(Tübingen, Germany): ACOU085 is a proprietary, first-in-class, small-molecule otoprotective drug candidate, which is currently being tested in a Phase 1b clinical trial involving age-related hearing loss (ARHL) patients. Designed to modulate a biologically validated target – the KCNQ4-encoded Kv7.4 potassium channel, which is essential for maintaining auditory function – ACOU085 is being developed for the treatment and prevention of hearing loss for a number of acquired and inherited forms of sensorineural hearing loss.
ACOU085 is characterized by a unique dual mode of action, which provides acute functional enhancement and long-term protection for the terminally differentiated sensorineural outer hair cells. “Being invited to share the translational background and progress of our ACOU085 lead program with the hearing loss drug development community at the Inner Ear Therapeutics Summit is an exciting opportunity for us,” says Dr. Jonas Dyhrfjeld-Johnsen, Chief Development Officer at Acousia Therapeutics. “I look forward to stimulating discussions with our peers in Boston.”
In addition to receiving an invitation to present “Small Molecule, KCNQ4 Agonist ACOU085 for the Treatment and Prevention of Hearing Loss”, Dr. Dyhrfjeld-Johnsen will also participate as a panelist on the panel discussion “De-risking the Early Development Process: A Robust and Comprehensive Early Development Process Is Essential to Minimize Setbacks Faced in the Clinic” and in the workshop “Mind The Gap: Calling Out the Shortfalls in the Current Inner Ear Therapeutic Development Pathway and Illuminating Solutions”.
About Acousia Therapeutics
Acousia Therapeutics GmbH is a privately-held, clinical stage biotech company based in Tübingen, Germany. The company is dedicated to the identification and development of small molecules for effective prevention and treatment of different etiologies of hearing loss. Acousia Therapeutics develops drugs for local and systemic administration.
Contacts
Tim Boelke,
M.D.
boelke@acousia.com
+49 70712988186
www.acousia.com
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Petrus Discloses Significant Stake in Iveco Group N.V.31.3.2026 12:00:00 CEST | Press release
ST. HELIER & LONDON, 31 March 2026 – Petrus Legal Strategies (Jersey) Limited, Petrus Advisers Limited and funds advised by Petrus Advisers Limited (together, “Petrus”), which together hold between 3% and 5% of Iveco Group N.V. (“Iveco”) common shares, today issued the following statement regarding Tata Motors’s proposed all-cash voluntary tender offer for Iveco at €14.10 per share: “We are currently reviewing the terms of the proposal and may provide further comments in due course. We look forward to engaging in a constructive dialogue with Iveco, Tata Motors and all other relevant stakeholders.” About Petrus Advisers and Petrus Legal Strategies Petrus Advisers is an FCA regulated alternative investment management firm. Headquartered in London, it was founded in 2009. Petrus has a successful track record investing in European equities based on its proprietary analysis and entrepreneurial investment approach. Petrus takes a constructive approach actively working together with the manag
Valle Venia presents: LPS feat. Natalia Sarsgard: J’ai dû m’arrêter27.3.2026 11:09:54 CET | Press release
(Neustadt an der Weinstrasse, Germany) The song by Leo Philipp Schmidt and Valle Venia captures the feeling of losing oneself in a world that is growing ever louder and faster, where restlessness and superficiality cause relationships, friendships, and connections to dissolve and be sacrificed. With emotional depth, singer Natalia Sarsgard describes the path to finding oneself again, to gathering one’s thoughts, to remaining silent, to withdrawing—in order to reflect in the silence, in the comfort, and in the seclusion, to feel and reconnect with ourselves and others. Through her multifaceted voice, Natalia Sarsgard’s interpretation of the song conveys how strength and courage can arise from deep vulnerability. Without even realizing it, one is accompanied by the confidence that what was thought to be lost can be found again. Youtube: https://youtu.be/CINjhTHtmno J'ai Du M'arreter - LPS, https://open.spotify.com/intl-de/album/6BvbJ0VAAvMwciCD7q7BC8 https://shop.valle-venia.de/products/
Innomotics is market leader for turbine replacement technology27.3.2026 08:58:02 CET | Press release
Innomotics wins several orders to provide motor and drive technology for turbine replacement projects, totaling a volume in the higher double-digit million EUR range Environmental, operational and financial benefits for many industries and industrial applications Geographic diversity underlines market potential
Changan and CAOA Strengthen Long-Term Commitment to Brazil with New R$ 5 Billion Investment Cycle and Breakthrough Flex-Fuel Technology27.3.2026 08:44:05 CET | Press release
(Anápolis, Brazil - March 26) Changan Automobile and CAOA today marked a new chapter for Brazil's automotive industry with the inauguration of a highly automated production line in Anápolis and the roll-off of the first Brazil-made CHANGAN UNI-T. The ceremony, attended by Brazilian President Luiz Inácio Lula da Silva and Vice-President Geraldo Alckmin, signals a decisive new phase of high-tech industrialization and green mobility in the country. The milestone underscores Changan's long-term commitment to the Brazilian market, backed by continuous investment in production capacity, technological modernization, and advanced manufacturing processes. The inauguration launches a new USD 950 million (R$ 5 billion) investment cycle spanning 2026 to 2028. Combined with the USD 570 million (R$ 3 billion) already invested between 2023 and 2025, total investment in the Anápolis complex reaches USD 1.52 billion (R$ 8 billion), bringing total annual capacity to 90,000 units. "For Changan, Brazil is
Swiss cloud provider Infomaniak launches automated radio with its radio streaming solution26.3.2026 09:14:55 CET | Press release
Geneva, 26 March 2026 – Infomaniak, the Swiss cloud provider already powering more than 6,000 radio and television stations across Europe and Africa, now makes it possible to run an online radio station 24/7, directly from a web browser, with no software, no encoder and no technical expertise required.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom